Next-generation Sequencing (NGS) Market by Product & Service (Consumables, Platforms, Services), Technology (SBS, Nanopore), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) - Global Forecast to 2027
Next-generation Sequencing (NGS) Market by Product & Service (Consumables, Platforms, Services), Technology (SBS, Nanopore), Application (Diagnostic, Drug Discovery, Agriculture), End User (Pharma, Biotech, Academic) - Global Forecast to 2027
Abstract
The global next-generation sequencing market is projected to reach USD 27.0 billion by 2027 from USD 13.0 billion in 2022, at a CAGR of 15.7% during the forecast period of 2022 to 2027. Increasing applications of NGS in cancer research, growing incidence of cancer and launch of new NGS platforms and consumables are some factors projected to drive the growth of the NGS market.
Consumables segment accounted for the largest share of next-generation sequencing market
On the basis of product & service, the next-generation sequencing market segmented into NGS consumables, sequencing services, presequencing products & services, NGS platforms, services for NGS platforms, and bioinformatics. In 2021, NGS consumables accounted for the largest share, owing to recent launch of new reagents and kits, and increasing in number of R&D activities in genomics.
Sequencing by synthesis segment accounted for the largest share of next-generation sequencing market
Based on technology, the next-generation sequencing market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing, and other sequencing technologies. In 2021, the sequencing by synthesis segment grabbed largest share in the NGS market owing to launch of new NGS platforms based on sequencing by synthesis technology.
The prominent players in NGS market are Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), Agilent Technologies (US), Eurofins Scientific (Luxembourg), Pacific Biosciences (US), Oxford Nanopore Technologies (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche AG (Switzerland), Brooks Automation (US), Psomagen, Inc. (US), 10x Genomics (US), Tecan Group (Switzerland), Zymo Research (US), Takara Bio (Japan), Promega Corporation (US), CD Genomics (US), New England Biolabs (US), and Novogene Corporation (China). Other players in the market include Hamilton Company (US), MedGenome (US), Becton, Dickinson and Company (US), Genotypic Technology (India), and LGC Limited (US).
“North America: Accounted for the largest share in the next-generation sequencing market”
North America accounted for the largest share of the next-generation sequencing market. Factors such as availability of research funding and the development of NGS data analysis solutions are the major factors driving the market growth.
The primary interviews conducted for this report can be categorized as follows:
•By Respondent: Supply Side- 80% and Demand Side - 20%
•By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%
•By Region: North America -20%, Europe -10%, Asia-Pacific -55%, RoW -15%
List of Companies Profiled in the Report:
•Illumina (US)
•Thermo Fisher Scientific (US)
•PerkinElmer (US)
•BGI Group (China)
•Agilent Technologies (US)
•Eurofins Scientific (Luxembourg)
•Pacific Biosciences (US)
•Oxford Nanopore Technologies (UK)
•QIAGEN (Netherlands)
•F. Hoffmann-La Roche AG (Switzerland)
•Brooks Automation (US)
•Psomagen, Inc. (US)
•10x Genomics (US)
•Tecan Group (Switzerland)
•Zymo Research (US)
•Takara Bio (Japan)
•Promega Corporation (US)
•CD Genomics (US)
•New England Biolabs (US)
•Novogene Corporation (China)
•Hamilton Company (US)
•MedGenome (US)
•Becton, Dickinson and Company (US)
•Genotypic Technology (India)
•LGC Limited (US)
Research Coverage:
This report provides a detailed picture of the next-generation sequencing market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end users and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall next-generation sequencing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.
Content
Table of Contents
1INTRODUCTION57
1.1STUDY OBJECTIVES57
1.2MARKET DEFINITION57
1.2.1INCLUSIONS AND EXCLUSIONS57
1.3MARKET SCOPE58
FIGURE 1NEXT-GENERATION SEQUENCING MARKET SEGMENTATION58
1.3.1YEARS CONSIDERED59
1.4CURRENCY CONSIDERED59
1.5LIMITATIONS59
1.6STAKEHOLDERS60
1.7SUMMARY OF CHANGES60
2RESEARCH METHODOLOGY61
2.1RESEARCH APPROACH61
FIGURE 2RESEARCH DESIGN61
2.1.1PRIMARY RESEARCH62
FIGURE 3NEXT-GENERATION SEQUENCING MARKET: PRIMARY RESPONDENTS62
2.2MARKET ESTIMATION METHODOLOGY63
FIGURE 4NEXT-GENERATION SEQUENCING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 202163
FIGURE 5MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 202164
2.2.1INSIGHTS FROM PRIMARY EXPERTS65
FIGURE 6MARKET SIZE VALIDATION FROM PRIMARY SOURCES65
2.3MARKET GROWTH RATE PROJECTIONS66
FIGURE 7NEXT-GENERATION SEQUENCING MARKET: CAGR PROJECTIONS, 2022–202767
FIGURE 8NEXT-GENERATION SEQUENCING MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS68
2.4DATA TRIANGULATION69
FIGURE 9DATA TRIANGULATION METHODOLOGY69
2.5RESEARCH ASSUMPTIONS69
2.6RISK ANALYSIS70
2.7RECESSION IMPACT70
TABLE 1GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)70
TABLE 2US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)71
TABLE 3US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)71
3EXECUTIVE SUMMARY72
FIGURE 10NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)72
FIGURE 11NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)73
FIGURE 12NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)74
FIGURE 13NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)75
FIGURE 14GEOGRAPHICAL SNAPSHOT OF NEXT-GENERATION SEQUENCING MARKET76
4PREMIUM INSIGHTS77
4.1NEXT-GENERATION SEQUENCING MARKET OVERVIEW77
FIGURE 15ADVANCEMENTS IN NGS TECHNOLOGIES TO DRIVE GROWTH77
4.2NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE AND COUNTRY (2021)78
FIGURE 16NGS CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 202178
4.3NEXT-GENERATION SEQUENCING MARKET SHARE, BY APPLICATION, 2022 VS. 202779
FIGURE 17DIAGNOSTICS SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 202779
4.4NEXT-GENERATION SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES79
FIGURE 18CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD79
5MARKET OVERVIEW80
5.1INTRODUCTION80
5.2MARKET DYNAMICS80
FIGURE 19NEXT-GENERATION SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES80
TABLE 4NEXT-GENERATION SEQUENCING MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES81
5.2.1DRIVERS81
5.2.1.1Advancements in NGS platforms81
5.2.1.1.1PromethION 2 Solo82
5.2.1.1.2Ion Torrent Genexus Dx82
5.2.1.1.3iSeq 100 system82
5.2.1.1.4Ion GeneStudio S582
5.2.1.2Declining cost of genome sequencing82
FIGURE 20COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–202183
5.2.1.3Improving regulatory and reimbursement scenarios for NGS-based diagnostic tests83
5.2.1.4Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research84
FIGURE 21NUMBER OF NEW CANCER CASES WORLDWIDE, 202084
TABLE 5CANCER INCIDENCE, 2020 VS. 204084
5.2.2RESTRAINTS85
5.2.2.1End-user budget constraints in developing countries85
5.2.3OPPORTUNITIES85
5.2.3.1Application of NGS in precision medicine and molecular diagnostics85
5.2.3.2Government and private support for large-scale sequencing86
TABLE 6GLOBAL SEQUENCING INITIATIVES86
5.2.3.3Advancements in NGS data analysis using big data87
FIGURE 22DATA PRODUCED DURING HUMAN WHOLE-GENOME SEQUENCING, 2001–201987
5.2.3.4Development of portable sequencing technologies88
5.2.3.5Partnerships and collaborations for technological advancements in NGS88
TABLE 7PARTNERSHIPS AND COLLABORATIONS, JANUARY 2018–DECEMBER 202288
5.2.4CHALLENGES89
5.2.4.1Interpretation of complex data from NGS platforms89
5.2.4.2Ethical issues89
5.2.4.3Introduction of alternative technologies89
5.3TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES90
FIGURE 23REVENUE SHIFT AND NEW REVENUE POCKETS90
5.4PRICING ANALYSIS90
TABLE 8AVERAGE SELLING PRICE OF NGS SYSTEMS, BY KEY PLAYER (2021)90
5.5TECHNOLOGY ANALYSIS91
TABLE 9SANGER SEQUENCING VS. NGS91
5.6VALUE CHAIN ANALYSIS92
FIGURE 24VALUE CHAIN ANALYSIS OF NEXT-GENERATION SEQUENCING MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE92
FIGURE 25VALUE CHAIN OF NEXT-GENERATION SEQUENCING ANALYSIS WORKFLOW: MAXIMUM VALUE ADDED DURING SEQUENCING AND ANALYSIS PHASES93
5.7ECOSYSTEM ANALYSIS94
FIGURE 26ECOSYSTEM ANALYSIS: NEXT-GENERATION SEQUENCING MARKET94
TABLE 10SUPPLY CHAIN ECOSYSTEM94
5.8KEY CONFERENCES AND EVENTS IN 2023–202496
TABLE 11NEXT-GENERATION SEQUENCING MARKET: LIST OF CONFERENCES AND EVENTS96
5.9PORTER’S FIVE FORCES ANALYSIS97
TABLE 12NEXT-GENERATION SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS97
5.9.1THREAT OF NEW ENTRANTS97
5.9.2THREAT OF SUBSTITUTES97
5.9.3BARGAINING POWER OF SUPPLIERS97
5.9.4BARGAINING POWER OF BUYERS98
5.9.5INTENSITY OF COMPETITIVE RIVALRY98
5.10KEY STAKEHOLDERS AND BUYING CRITERIA98
FIGURE 27INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NGS PRODUCTS AND SERVICES98
FIGURE 28BUYING CRITERIA FOR NGS PRODUCTS98
5.11PATENT ANALYSIS99
FIGURE 29PATENT APPLICATIONS RELATED TO NGS MARKET, JANUARY 2012–DECEMBER 202299
5.12REGULATORY ANALYSIS100
5.12.1NORTH AMERICA100
5.12.1.1US100
TABLE 13US FDA: MEDICAL DEVICE CLASSIFICATION101
TABLE 14US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS101
5.12.1.2Canada101
5.12.2EUROPE101
5.12.3ASIA PACIFIC102
5.12.3.1China102
TABLE 15CHINA: CLASSIFICATION OF MEDICAL DEVICES102
5.12.3.2Japan103
5.12.3.3India103
5.12.4LATIN AMERICA103
5.12.5MIDDLE EAST104
6NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE105
6.1INTRODUCTION106
TABLE 16NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)106
6.2NGS CONSUMABLES106
6.2.1GROWING NUMBER OF SEQUENCING PROCEDURES TO PROPEL DEMAND FOR NGS CONSUMABLES106
TABLE 17NGS CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)107
TABLE 18NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)107
TABLE 19EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)107
TABLE 20ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)108
TABLE 21LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)108
TABLE 22MIDDLE EAST & AFRICA: NGS CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)108
6.3SEQUENCING SERVICES109
TABLE 23SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)109
TABLE 24SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)110
TABLE 25NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)110
TABLE 26EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)110
TABLE 27ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)111
TABLE 28LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)111
TABLE 29MIDDLE EAST & AFRICA: SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)111
6.3.1EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS112
6.3.1.1Development of technologically advanced NGS products and services to propel growth112
TABLE 30EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2020–2027 (USD MILLION)112
TABLE 31NORTH AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)113
TABLE 32EUROPE: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)113
TABLE 33ASIA PACIFIC: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)114
TABLE 34LATIN AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)114
TABLE 35MIDDLE EAST & AFRICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2020–2027 (USD MILLION)114
6.3.2RNA SEQUENCING115
6.3.2.1Launch of RNA sequencing services to drive growth115
TABLE 36RNA SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)115
TABLE 37NORTH AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)116
TABLE 38EUROPE: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)116
TABLE 39ASIA PACIFIC: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)116
TABLE 40LATIN AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)117
TABLE 41MIDDLE EAST & AFRICA: RNA SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)117
6.3.3DE NOVO SEQUENCING117
6.3.3.1Rising awareness about advantages of De Novo sequencing to support growth117
TABLE 42DE NOVO SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)118
TABLE 43NORTH AMERICA: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)118
TABLE 44EUROPE: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)119
TABLE 45ASIA PACIFIC: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)119
TABLE 46LATIN AMERICA: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)120
TABLE 47MIDDLE EAST & AFRICA: DE NOVO SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)120
6.3.4CHIP SEQUENCING120
6.3.4.1Increasing demand for ChIP sequencing services to propel growth120
TABLE 48CHIP SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)121
TABLE 49NORTH AMERICA: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)121
TABLE 50EUROPE: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)122
TABLE 51ASIA PACIFIC: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)122
TABLE 52LATIN AMERICA: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)122
TABLE 53MIDDLE EAST & AFRICA: CHIP SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)123
6.3.5WHOLE-GENOME SEQUENCING123
6.3.5.1Reducing whole-genome sequencing costs to propel growth123
TABLE 54WHOLE-GENOME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)124
TABLE 55NORTH AMERICA: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)124
TABLE 56EUROPE: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)124
TABLE 57ASIA PACIFIC: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)125
TABLE 58LATIN AMERICA: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)125
TABLE 59MIDDLE EAST & AFRICA: WHOLE-GENOME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)125
6.3.6METHYL SEQUENCING126
6.3.6.1Rising importance of DNA methylation in study of cancer to drive growth126
TABLE 60METHYL SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)126
TABLE 61NORTH AMERICA: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)126
TABLE 62EUROPE: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)127
TABLE 63ASIA PACIFIC: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)127
TABLE 64LATIN AMERICA: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)127
TABLE 65MIDDLE EAST & AFRICA: METHYL SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)128
6.3.7OTHER SEQUENCING SERVICES128
TABLE 66OTHER SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)128
TABLE 67NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)128
TABLE 68EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)129
TABLE 69ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)129
TABLE 70LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)130
TABLE 71MIDDLE EAST & AFRICA: OTHER SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)130
6.4PRE-SEQUENCING PRODUCTS & SERVICES130
TABLE 72PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)131
TABLE 73PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)131
TABLE 74NORTH AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)131
TABLE 75EUROPE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)132
TABLE 76ASIA PACIFIC: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)132
TABLE 77LATIN AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)133
TABLE 78MIDDLE EAST & AFRICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)133
6.4.1LIBRARY PREPARATION AND TARGET ENRICHMENT133
6.4.1.1Development of advanced library preparation solutions to boost growth133
TABLE 79LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY REGION, 2020–2027 (USD MILLION)135
TABLE 80NORTH AMERICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)135
TABLE 81EUROPE: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)136
TABLE 82ASIA PACIFIC: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)136
TABLE 83LATIN AMERICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)137
TABLE 84MIDDLE EAST & AFRICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY REGION, 2020–2027 (USD MILLION)137
6.4.2QUALITY CONTROL137
6.4.2.1Importance of quality control in NGS workflow to drive growth137
TABLE 85QUALITY CONTROL MARKET, BY REGION, 2020–2027 (USD MILLION)138
TABLE 86NORTH AMERICA: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)138
TABLE 87EUROPE: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)138
TABLE 88ASIA PACIFIC: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)139
TABLE 89LATIN AMERICA: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)139
TABLE 90MIDDLE EAST & AFRICA: QUALITY CONTROL MARKET, BY REGION, 2020–2027 (USD MILLION)139
6.5NGS PLATFORMS140
TABLE 91NGS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)140
TABLE 92NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)141
TABLE 93NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)141
TABLE 94EUROPE: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)141
TABLE 95ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)142
TABLE 96LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)142
TABLE 97MIDDLE EAST & AFRICA: NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)142
6.5.1ILLUMINA143
TABLE 98ILLUMINA NGS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)143
TABLE 99ILLUMINA NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)144
6.5.1.1NovaSeq systems144
TABLE 100NOVASEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)145
6.5.1.2NextSeq systems145
TABLE 101NEXTSEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)146
6.5.1.3MiSeq systems146
TABLE 102MISEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)146
6.5.1.4iSeq 100 systems147
TABLE 103ISEQ 100 SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)147
6.5.1.5MiniSeq systems147
TABLE 104MINISEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)147
6.5.2THERMO FISHER SCIENTIFIC148
TABLE 105THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)148
TABLE 106THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)148
6.5.3OXFORD NANOPORE TECHNOLOGIES149
TABLE 107OXFORD NANOPORE TECHNOLOGIES NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)149
6.5.4PACIFIC BIOSCIENCES150
TABLE 108PACIFIC BIOSCIENCES NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)150
6.5.5OTHER NGS PLATFORMS150
TABLE 109OTHER NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)151
6.6BIOINFORMATICS151
TABLE 110BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)151
TABLE 111BIOINFORMATICS MARKET, BY REGION, 2020–2027 (USD MILLION)152
TABLE 112NORTH AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)152
TABLE 113EUROPE: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)152
TABLE 114ASIA PACIFIC: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)153
TABLE 115LATIN AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)153
TABLE 116MIDDLE EAST & AFRICA: BIOINFORMATICS MARKET, BY REGION, 2020–2027 (USD MILLION)153
6.6.1NGS DATA ANALYSIS SERVICES154
6.6.1.1Rising awareness about NGS data analysis services to boost growth154
TABLE 117NGS DATA ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)154
TABLE 118NORTH AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)154
TABLE 119EUROPE: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)155
TABLE 120ASIA PACIFIC: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)155
TABLE 121LATIN AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)156
TABLE 122MIDDLE EAST & AFRICA: NGS DATA ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)156
6.6.2NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES156
6.6.2.1Development of advanced bioinformatics solutions to drive growth156
TABLE 123NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY REGION, 2020–2027 (USD MILLION)157
TABLE 124NORTH AMERICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)157
TABLE 125EUROPE: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)158
TABLE 126ASIA PACIFIC: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)158
TABLE 127LATIN AMERICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)159
TABLE 128MIDDLE EAST & AFRICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY REGION, 2020–2027 (USD MILLION)159
6.6.3NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS159
6.6.3.1Launch of cloud-based solutions to drive market159
TABLE 129NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)160
TABLE 130NORTH AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)160
TABLE 131EUROPE: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)161
TABLE 132ASIA PACIFIC: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)161
TABLE 133LATIN AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)162
TABLE 134MIDDLE EAST & AFRICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)162
6.7SERVICES FOR NGS PLATFORMS163
6.7.1INCREASING INSTALLATION OF NGS PLATFORMS TO SUPPORT GROWTH163
TABLE 135SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)163
TABLE 136NORTH AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)163
TABLE 137EUROPE: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)164
TABLE 138ASIA PACIFIC: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)164
TABLE 139LATIN AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)165
TABLE 140MIDDLE EAST & AFRICA: SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)165
7NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY166
7.1INTRODUCTION167
TABLE 141NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY COMPANY167
TABLE 142NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)168
7.2SEQUENCING BY SYNTHESIS168
7.2.1SBS TECHNOLOGY ENABLES HIGHEST PRODUCTION OF BASE PAIRS IN SHORT TIME PERIOD168
TABLE 143SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2020–2027 (USD MILLION)169
TABLE 144NORTH AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)169
TABLE 145EUROPE: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)170
TABLE 146ASIA PACIFIC: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)170
TABLE 147LATIN AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)171
TABLE 148MIDDLE EAST & AFRICA: SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2020–2027 (USD MILLION)171
7.3ION SEMICONDUCTOR SEQUENCING171
7.3.1SIMPLER WORKFLOW AND COST-EFFECTIVENESS ARE ADVANTAGES OF ION SEMICONDUCTOR SEQUENCING171
TABLE 149ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)172
TABLE 150NORTH AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)172
TABLE 151EUROPE: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)173
TABLE 152ASIA PACIFIC: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)173
TABLE 153LATIN AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)174
TABLE 154MIDDLE EAST & AFRICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)174
7.4NANOPORE SEQUENCING174
7.4.1NANOPORE SEQUENCING—ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES174
TABLE 155NANOPORE SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)175
TABLE 156NORTH AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)175
TABLE 157EUROPE: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)176
TABLE 158ASIA PACIFIC: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)176
TABLE 159LATIN AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)176
TABLE 160MIDDLE EAST & AFRICA: NANOPORE SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)177
7.5SINGLE-MOLECULE REAL-TIME SEQUENCING177
7.5.1SMRT SEQUENCING PRODUCES RESULTS IN SHORT TIME AND AT LOWER COSTS177
TABLE 161SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)178
TABLE 162NORTH AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)178
TABLE 163EUROPE: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)179
TABLE 164ASIA PACIFIC: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)179
TABLE 165LATIN AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)180
TABLE 166MIDDLE EAST & AFRICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)180
7.6OTHER SEQUENCING TECHNOLOGIES180
TABLE 167OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2020–2027 (USD MILLION)180
TABLE 168NORTH AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)181
TABLE 169EUROPE: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)181
TABLE 170ASIA PACIFIC: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)182
TABLE 171LATIN AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)182
TABLE 172MIDDLE EAST & AFRICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2020–2027 (USD MILLION)182
8NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION183
8.1INTRODUCTION184
TABLE 173NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)184
8.2DIAGNOSTICS184
TABLE 174NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)185
TABLE 175NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)185
TABLE 176NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)186
TABLE 177EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)186
TABLE 178ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)187
TABLE 179LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)187
TABLE 180MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)187
8.2.1CANCER DIAGNOSTICS188
8.2.1.1High adoption of NGS in cancer diagnostics to propel growth188
TABLE 181NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)189
TABLE 182NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)189
TABLE 183EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)190
TABLE 184ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)190
TABLE 185LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)191
TABLE 186MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)191
8.2.2INFECTIOUS DISEASE DIAGNOSTICS191
8.2.2.1Applications in infectious disease surveillance and launch of new tests to drive growth191
TABLE 187NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)192
TABLE 188NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)192
TABLE 189EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)193
TABLE 190ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)193
TABLE 191LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)194
TABLE 192MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)194
8.2.3REPRODUCTIVE HEALTH DIAGNOSTICS194
8.2.3.1Extensive use of NGS in NIPT to boost growth194
TABLE 193NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)195
TABLE 194NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)196
TABLE 195EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)196
TABLE 196ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)197
TABLE 197LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)197
TABLE 198MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)197
8.2.4OTHER DIAGNOSTIC APPLICATIONS198
TABLE 199NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)198
TABLE 200NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)198
TABLE 201EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)199
TABLE 202ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)199
TABLE 203LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)200
TABLE 204MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)200
8.3DRUG DISCOVERY AND DEVELOPMENT200
TABLE 205NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)201
TABLE 206NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION)201
TABLE 207NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)202
TABLE 208EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)202
TABLE 209ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)203
TABLE 210LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)203
TABLE 211MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION)203
8.3.1PHARMACOGENOMICS204
8.3.1.1Advent of NGS to understand genomic variants in humans to drive growth204
TABLE 212NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY REGION, 2020–2027 (USD MILLION)204
TABLE 213NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)205
TABLE 214EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)205
TABLE 215ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)206
TABLE 216LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)206
TABLE 217MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY REGION, 2020–2027 (USD MILLION)206
8.3.2OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS207
TABLE 218NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)207
TABLE 219NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)207
TABLE 220EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)208
TABLE 221ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)208
TABLE 222LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)209
TABLE 223MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)209
8.4AGRICULTURAL AND ANIMAL RESEARCH209
8.4.1NGS-BASED ROUTINE SCREENING IN AGRICULTURE TO BOOST MARKET GROWTH209
TABLE 224NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY REGION, 2020–2027 (USD MILLION)210
TABLE 225NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)210
TABLE 226EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)211
TABLE 227ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)211
TABLE 228LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)212
TABLE 229MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY REGION, 2020–2027 (USD MILLION)212
8.5OTHER APPLICATIONS213
TABLE 230NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–202
Consumables segment accounted for the largest share of next-generation sequencing market
On the basis of product & service, the next-generation sequencing market segmented into NGS consumables, sequencing services, presequencing products & services, NGS platforms, services for NGS platforms, and bioinformatics. In 2021, NGS consumables accounted for the largest share, owing to recent launch of new reagents and kits, and increasing in number of R&D activities in genomics.
Sequencing by synthesis segment accounted for the largest share of next-generation sequencing market
Based on technology, the next-generation sequencing market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing, and other sequencing technologies. In 2021, the sequencing by synthesis segment grabbed largest share in the NGS market owing to launch of new NGS platforms based on sequencing by synthesis technology.
The prominent players in NGS market are Illumina (US), Thermo Fisher Scientific (US), PerkinElmer (US), BGI Group (China), Agilent Technologies (US), Eurofins Scientific (Luxembourg), Pacific Biosciences (US), Oxford Nanopore Technologies (UK), QIAGEN (Netherlands), F. Hoffmann-La Roche AG (Switzerland), Brooks Automation (US), Psomagen, Inc. (US), 10x Genomics (US), Tecan Group (Switzerland), Zymo Research (US), Takara Bio (Japan), Promega Corporation (US), CD Genomics (US), New England Biolabs (US), and Novogene Corporation (China). Other players in the market include Hamilton Company (US), MedGenome (US), Becton, Dickinson and Company (US), Genotypic Technology (India), and LGC Limited (US).
“North America: Accounted for the largest share in the next-generation sequencing market”
North America accounted for the largest share of the next-generation sequencing market. Factors such as availability of research funding and the development of NGS data analysis solutions are the major factors driving the market growth.
The primary interviews conducted for this report can be categorized as follows:
•By Respondent: Supply Side- 80% and Demand Side - 20%
•By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%
•By Region: North America -20%, Europe -10%, Asia-Pacific -55%, RoW -15%
List of Companies Profiled in the Report:
•Illumina (US)
•Thermo Fisher Scientific (US)
•PerkinElmer (US)
•BGI Group (China)
•Agilent Technologies (US)
•Eurofins Scientific (Luxembourg)
•Pacific Biosciences (US)
•Oxford Nanopore Technologies (UK)
•QIAGEN (Netherlands)
•F. Hoffmann-La Roche AG (Switzerland)
•Brooks Automation (US)
•Psomagen, Inc. (US)
•10x Genomics (US)
•Tecan Group (Switzerland)
•Zymo Research (US)
•Takara Bio (Japan)
•Promega Corporation (US)
•CD Genomics (US)
•New England Biolabs (US)
•Novogene Corporation (China)
•Hamilton Company (US)
•MedGenome (US)
•Becton, Dickinson and Company (US)
•Genotypic Technology (India)
•LGC Limited (US)
Research Coverage:
This report provides a detailed picture of the next-generation sequencing market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end users and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall next-generation sequencing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.
1INTRODUCTION57
1.1STUDY OBJECTIVES57
1.2MARKET DEFINITION57
1.2.1INCLUSIONS AND EXCLUSIONS57
1.3MARKET SCOPE58
FIGURE 1NEXT-GENERATION SEQUENCING MARKET SEGMENTATION58
1.3.1YEARS CONSIDERED59
1.4CURRENCY CONSIDERED59
1.5LIMITATIONS59
1.6STAKEHOLDERS60
1.7SUMMARY OF CHANGES60
2RESEARCH METHODOLOGY61
2.1RESEARCH APPROACH61
FIGURE 2RESEARCH DESIGN61
2.1.1PRIMARY RESEARCH62
FIGURE 3NEXT-GENERATION SEQUENCING MARKET: PRIMARY RESPONDENTS62
2.2MARKET ESTIMATION METHODOLOGY63
FIGURE 4NEXT-GENERATION SEQUENCING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 202163
FIGURE 5MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 202164
2.2.1INSIGHTS FROM PRIMARY EXPERTS65
FIGURE 6MARKET SIZE VALIDATION FROM PRIMARY SOURCES65
2.3MARKET GROWTH RATE PROJECTIONS66
FIGURE 7NEXT-GENERATION SEQUENCING MARKET: CAGR PROJECTIONS, 2022–202767
FIGURE 8NEXT-GENERATION SEQUENCING MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS68
2.4DATA TRIANGULATION69
FIGURE 9DATA TRIANGULATION METHODOLOGY69
2.5RESEARCH ASSUMPTIONS69
2.6RISK ANALYSIS70
2.7RECESSION IMPACT70
TABLE 1GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)70
TABLE 2US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)71
TABLE 3US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)71
3EXECUTIVE SUMMARY72
FIGURE 10NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)72
FIGURE 11NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)73
FIGURE 12NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)74
FIGURE 13NEXT-GENERATION SEQUENCING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)75
FIGURE 14GEOGRAPHICAL SNAPSHOT OF NEXT-GENERATION SEQUENCING MARKET76
4PREMIUM INSIGHTS77
4.1NEXT-GENERATION SEQUENCING MARKET OVERVIEW77
FIGURE 15ADVANCEMENTS IN NGS TECHNOLOGIES TO DRIVE GROWTH77
4.2NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE AND COUNTRY (2021)78
FIGURE 16NGS CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 202178
4.3NEXT-GENERATION SEQUENCING MARKET SHARE, BY APPLICATION, 2022 VS. 202779
FIGURE 17DIAGNOSTICS SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 202779
4.4NEXT-GENERATION SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES79
FIGURE 18CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD79
5MARKET OVERVIEW80
5.1INTRODUCTION80
5.2MARKET DYNAMICS80
FIGURE 19NEXT-GENERATION SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES80
TABLE 4NEXT-GENERATION SEQUENCING MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES81
5.2.1DRIVERS81
5.2.1.1Advancements in NGS platforms81
5.2.1.1.1PromethION 2 Solo82
5.2.1.1.2Ion Torrent Genexus Dx82
5.2.1.1.3iSeq 100 system82
5.2.1.1.4Ion GeneStudio S582
5.2.1.2Declining cost of genome sequencing82
FIGURE 20COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–202183
5.2.1.3Improving regulatory and reimbursement scenarios for NGS-based diagnostic tests83
5.2.1.4Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research84
FIGURE 21NUMBER OF NEW CANCER CASES WORLDWIDE, 202084
TABLE 5CANCER INCIDENCE, 2020 VS. 204084
5.2.2RESTRAINTS85
5.2.2.1End-user budget constraints in developing countries85
5.2.3OPPORTUNITIES85
5.2.3.1Application of NGS in precision medicine and molecular diagnostics85
5.2.3.2Government and private support for large-scale sequencing86
TABLE 6GLOBAL SEQUENCING INITIATIVES86
5.2.3.3Advancements in NGS data analysis using big data87
FIGURE 22DATA PRODUCED DURING HUMAN WHOLE-GENOME SEQUENCING, 2001–201987
5.2.3.4Development of portable sequencing technologies88
5.2.3.5Partnerships and collaborations for technological advancements in NGS88
TABLE 7PARTNERSHIPS AND COLLABORATIONS, JANUARY 2018–DECEMBER 202288
5.2.4CHALLENGES89
5.2.4.1Interpretation of complex data from NGS platforms89
5.2.4.2Ethical issues89
5.2.4.3Introduction of alternative technologies89
5.3TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES90
FIGURE 23REVENUE SHIFT AND NEW REVENUE POCKETS90
5.4PRICING ANALYSIS90
TABLE 8AVERAGE SELLING PRICE OF NGS SYSTEMS, BY KEY PLAYER (2021)90
5.5TECHNOLOGY ANALYSIS91
TABLE 9SANGER SEQUENCING VS. NGS91
5.6VALUE CHAIN ANALYSIS92
FIGURE 24VALUE CHAIN ANALYSIS OF NEXT-GENERATION SEQUENCING MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE92
FIGURE 25VALUE CHAIN OF NEXT-GENERATION SEQUENCING ANALYSIS WORKFLOW: MAXIMUM VALUE ADDED DURING SEQUENCING AND ANALYSIS PHASES93
5.7ECOSYSTEM ANALYSIS94
FIGURE 26ECOSYSTEM ANALYSIS: NEXT-GENERATION SEQUENCING MARKET94
TABLE 10SUPPLY CHAIN ECOSYSTEM94
5.8KEY CONFERENCES AND EVENTS IN 2023–202496
TABLE 11NEXT-GENERATION SEQUENCING MARKET: LIST OF CONFERENCES AND EVENTS96
5.9PORTER’S FIVE FORCES ANALYSIS97
TABLE 12NEXT-GENERATION SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS97
5.9.1THREAT OF NEW ENTRANTS97
5.9.2THREAT OF SUBSTITUTES97
5.9.3BARGAINING POWER OF SUPPLIERS97
5.9.4BARGAINING POWER OF BUYERS98
5.9.5INTENSITY OF COMPETITIVE RIVALRY98
5.10KEY STAKEHOLDERS AND BUYING CRITERIA98
FIGURE 27INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NGS PRODUCTS AND SERVICES98
FIGURE 28BUYING CRITERIA FOR NGS PRODUCTS98
5.11PATENT ANALYSIS99
FIGURE 29PATENT APPLICATIONS RELATED TO NGS MARKET, JANUARY 2012–DECEMBER 202299
5.12REGULATORY ANALYSIS100
5.12.1NORTH AMERICA100
5.12.1.1US100
TABLE 13US FDA: MEDICAL DEVICE CLASSIFICATION101
TABLE 14US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS101
5.12.1.2Canada101
5.12.2EUROPE101
5.12.3ASIA PACIFIC102
5.12.3.1China102
TABLE 15CHINA: CLASSIFICATION OF MEDICAL DEVICES102
5.12.3.2Japan103
5.12.3.3India103
5.12.4LATIN AMERICA103
5.12.5MIDDLE EAST104
6NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE105
6.1INTRODUCTION106
TABLE 16NEXT-GENERATION SEQUENCING MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)106
6.2NGS CONSUMABLES106
6.2.1GROWING NUMBER OF SEQUENCING PROCEDURES TO PROPEL DEMAND FOR NGS CONSUMABLES106
TABLE 17NGS CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)107
TABLE 18NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)107
TABLE 19EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)107
TABLE 20ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)108
TABLE 21LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)108
TABLE 22MIDDLE EAST & AFRICA: NGS CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)108
6.3SEQUENCING SERVICES109
TABLE 23SEQUENCING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)109
TABLE 24SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)110
TABLE 25NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)110
TABLE 26EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)110
TABLE 27ASIA PACIFIC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)111
TABLE 28LATIN AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)111
TABLE 29MIDDLE EAST & AFRICA: SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)111
6.3.1EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS112
6.3.1.1Development of technologically advanced NGS products and services to propel growth112
TABLE 30EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2020–2027 (USD MILLION)112
TABLE 31NORTH AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)113
TABLE 32EUROPE: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)113
TABLE 33ASIA PACIFIC: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)114
TABLE 34LATIN AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)114
TABLE 35MIDDLE EAST & AFRICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2020–2027 (USD MILLION)114
6.3.2RNA SEQUENCING115
6.3.2.1Launch of RNA sequencing services to drive growth115
TABLE 36RNA SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)115
TABLE 37NORTH AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)116
TABLE 38EUROPE: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)116
TABLE 39ASIA PACIFIC: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)116
TABLE 40LATIN AMERICA: RNA SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)117
TABLE 41MIDDLE EAST & AFRICA: RNA SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)117
6.3.3DE NOVO SEQUENCING117
6.3.3.1Rising awareness about advantages of De Novo sequencing to support growth117
TABLE 42DE NOVO SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)118
TABLE 43NORTH AMERICA: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)118
TABLE 44EUROPE: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)119
TABLE 45ASIA PACIFIC: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)119
TABLE 46LATIN AMERICA: DE NOVO SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)120
TABLE 47MIDDLE EAST & AFRICA: DE NOVO SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)120
6.3.4CHIP SEQUENCING120
6.3.4.1Increasing demand for ChIP sequencing services to propel growth120
TABLE 48CHIP SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)121
TABLE 49NORTH AMERICA: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)121
TABLE 50EUROPE: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)122
TABLE 51ASIA PACIFIC: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)122
TABLE 52LATIN AMERICA: CHIP SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)122
TABLE 53MIDDLE EAST & AFRICA: CHIP SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)123
6.3.5WHOLE-GENOME SEQUENCING123
6.3.5.1Reducing whole-genome sequencing costs to propel growth123
TABLE 54WHOLE-GENOME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)124
TABLE 55NORTH AMERICA: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)124
TABLE 56EUROPE: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)124
TABLE 57ASIA PACIFIC: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)125
TABLE 58LATIN AMERICA: WHOLE-GENOME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)125
TABLE 59MIDDLE EAST & AFRICA: WHOLE-GENOME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)125
6.3.6METHYL SEQUENCING126
6.3.6.1Rising importance of DNA methylation in study of cancer to drive growth126
TABLE 60METHYL SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)126
TABLE 61NORTH AMERICA: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)126
TABLE 62EUROPE: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)127
TABLE 63ASIA PACIFIC: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)127
TABLE 64LATIN AMERICA: METHYL SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)127
TABLE 65MIDDLE EAST & AFRICA: METHYL SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)128
6.3.7OTHER SEQUENCING SERVICES128
TABLE 66OTHER SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)128
TABLE 67NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)128
TABLE 68EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)129
TABLE 69ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)129
TABLE 70LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)130
TABLE 71MIDDLE EAST & AFRICA: OTHER SEQUENCING SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)130
6.4PRE-SEQUENCING PRODUCTS & SERVICES130
TABLE 72PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)131
TABLE 73PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)131
TABLE 74NORTH AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)131
TABLE 75EUROPE: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)132
TABLE 76ASIA PACIFIC: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)132
TABLE 77LATIN AMERICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)133
TABLE 78MIDDLE EAST & AFRICA: PRE-SEQUENCING PRODUCTS & SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)133
6.4.1LIBRARY PREPARATION AND TARGET ENRICHMENT133
6.4.1.1Development of advanced library preparation solutions to boost growth133
TABLE 79LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY REGION, 2020–2027 (USD MILLION)135
TABLE 80NORTH AMERICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)135
TABLE 81EUROPE: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)136
TABLE 82ASIA PACIFIC: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)136
TABLE 83LATIN AMERICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)137
TABLE 84MIDDLE EAST & AFRICA: LIBRARY PREPARATION AND TARGET ENRICHMENT MARKET, BY REGION, 2020–2027 (USD MILLION)137
6.4.2QUALITY CONTROL137
6.4.2.1Importance of quality control in NGS workflow to drive growth137
TABLE 85QUALITY CONTROL MARKET, BY REGION, 2020–2027 (USD MILLION)138
TABLE 86NORTH AMERICA: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)138
TABLE 87EUROPE: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)138
TABLE 88ASIA PACIFIC: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)139
TABLE 89LATIN AMERICA: QUALITY CONTROL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)139
TABLE 90MIDDLE EAST & AFRICA: QUALITY CONTROL MARKET, BY REGION, 2020–2027 (USD MILLION)139
6.5NGS PLATFORMS140
TABLE 91NGS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)140
TABLE 92NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)141
TABLE 93NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)141
TABLE 94EUROPE: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)141
TABLE 95ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)142
TABLE 96LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)142
TABLE 97MIDDLE EAST & AFRICA: NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)142
6.5.1ILLUMINA143
TABLE 98ILLUMINA NGS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)143
TABLE 99ILLUMINA NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)144
6.5.1.1NovaSeq systems144
TABLE 100NOVASEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)145
6.5.1.2NextSeq systems145
TABLE 101NEXTSEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)146
6.5.1.3MiSeq systems146
TABLE 102MISEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)146
6.5.1.4iSeq 100 systems147
TABLE 103ISEQ 100 SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)147
6.5.1.5MiniSeq systems147
TABLE 104MINISEQ SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)147
6.5.2THERMO FISHER SCIENTIFIC148
TABLE 105THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY TYPE, 2020–2027 (USD MILLION)148
TABLE 106THERMO FISHER SCIENTIFIC NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)148
6.5.3OXFORD NANOPORE TECHNOLOGIES149
TABLE 107OXFORD NANOPORE TECHNOLOGIES NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)149
6.5.4PACIFIC BIOSCIENCES150
TABLE 108PACIFIC BIOSCIENCES NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)150
6.5.5OTHER NGS PLATFORMS150
TABLE 109OTHER NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)151
6.6BIOINFORMATICS151
TABLE 110BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)151
TABLE 111BIOINFORMATICS MARKET, BY REGION, 2020–2027 (USD MILLION)152
TABLE 112NORTH AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)152
TABLE 113EUROPE: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)152
TABLE 114ASIA PACIFIC: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)153
TABLE 115LATIN AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)153
TABLE 116MIDDLE EAST & AFRICA: BIOINFORMATICS MARKET, BY REGION, 2020–2027 (USD MILLION)153
6.6.1NGS DATA ANALYSIS SERVICES154
6.6.1.1Rising awareness about NGS data analysis services to boost growth154
TABLE 117NGS DATA ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)154
TABLE 118NORTH AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)154
TABLE 119EUROPE: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)155
TABLE 120ASIA PACIFIC: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)155
TABLE 121LATIN AMERICA: NGS DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)156
TABLE 122MIDDLE EAST & AFRICA: NGS DATA ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)156
6.6.2NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES156
6.6.2.1Development of advanced bioinformatics solutions to drive growth156
TABLE 123NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY REGION, 2020–2027 (USD MILLION)157
TABLE 124NORTH AMERICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)157
TABLE 125EUROPE: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)158
TABLE 126ASIA PACIFIC: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)158
TABLE 127LATIN AMERICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)159
TABLE 128MIDDLE EAST & AFRICA: NGS DATA ANALYSIS SOFTWARE AND WORKBENCHES MARKET, BY REGION, 2020–2027 (USD MILLION)159
6.6.3NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS159
6.6.3.1Launch of cloud-based solutions to drive market159
TABLE 129NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)160
TABLE 130NORTH AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)160
TABLE 131EUROPE: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)161
TABLE 132ASIA PACIFIC: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)161
TABLE 133LATIN AMERICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)162
TABLE 134MIDDLE EAST & AFRICA: NGS STORAGE, MANAGEMENT, AND CLOUD COMPUTING SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION)162
6.7SERVICES FOR NGS PLATFORMS163
6.7.1INCREASING INSTALLATION OF NGS PLATFORMS TO SUPPORT GROWTH163
TABLE 135SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)163
TABLE 136NORTH AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)163
TABLE 137EUROPE: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)164
TABLE 138ASIA PACIFIC: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)164
TABLE 139LATIN AMERICA: SERVICES FOR NGS PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)165
TABLE 140MIDDLE EAST & AFRICA: SERVICES FOR NGS PLATFORMS MARKET, BY REGION, 2020–2027 (USD MILLION)165
7NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY166
7.1INTRODUCTION167
TABLE 141NEXT-GENERATION SEQUENCING TECHNOLOGIES, BY COMPANY167
TABLE 142NEXT-GENERATION SEQUENCING MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)168
7.2SEQUENCING BY SYNTHESIS168
7.2.1SBS TECHNOLOGY ENABLES HIGHEST PRODUCTION OF BASE PAIRS IN SHORT TIME PERIOD168
TABLE 143SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2020–2027 (USD MILLION)169
TABLE 144NORTH AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)169
TABLE 145EUROPE: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)170
TABLE 146ASIA PACIFIC: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)170
TABLE 147LATIN AMERICA: SEQUENCING BY SYNTHESIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)171
TABLE 148MIDDLE EAST & AFRICA: SEQUENCING BY SYNTHESIS MARKET, BY REGION, 2020–2027 (USD MILLION)171
7.3ION SEMICONDUCTOR SEQUENCING171
7.3.1SIMPLER WORKFLOW AND COST-EFFECTIVENESS ARE ADVANTAGES OF ION SEMICONDUCTOR SEQUENCING171
TABLE 149ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)172
TABLE 150NORTH AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)172
TABLE 151EUROPE: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)173
TABLE 152ASIA PACIFIC: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)173
TABLE 153LATIN AMERICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)174
TABLE 154MIDDLE EAST & AFRICA: ION SEMICONDUCTOR SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)174
7.4NANOPORE SEQUENCING174
7.4.1NANOPORE SEQUENCING—ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES174
TABLE 155NANOPORE SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)175
TABLE 156NORTH AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)175
TABLE 157EUROPE: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)176
TABLE 158ASIA PACIFIC: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)176
TABLE 159LATIN AMERICA: NANOPORE SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)176
TABLE 160MIDDLE EAST & AFRICA: NANOPORE SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)177
7.5SINGLE-MOLECULE REAL-TIME SEQUENCING177
7.5.1SMRT SEQUENCING PRODUCES RESULTS IN SHORT TIME AND AT LOWER COSTS177
TABLE 161SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)178
TABLE 162NORTH AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)178
TABLE 163EUROPE: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)179
TABLE 164ASIA PACIFIC: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)179
TABLE 165LATIN AMERICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)180
TABLE 166MIDDLE EAST & AFRICA: SINGLE-MOLECULE REAL-TIME SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION)180
7.6OTHER SEQUENCING TECHNOLOGIES180
TABLE 167OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2020–2027 (USD MILLION)180
TABLE 168NORTH AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)181
TABLE 169EUROPE: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)181
TABLE 170ASIA PACIFIC: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)182
TABLE 171LATIN AMERICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)182
TABLE 172MIDDLE EAST & AFRICA: OTHER SEQUENCING TECHNOLOGIES MARKET, BY REGION, 2020–2027 (USD MILLION)182
8NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION183
8.1INTRODUCTION184
TABLE 173NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)184
8.2DIAGNOSTICS184
TABLE 174NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY TYPE, 2020–2027 (USD MILLION)185
TABLE 175NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)185
TABLE 176NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)186
TABLE 177EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)186
TABLE 178ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)187
TABLE 179LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)187
TABLE 180MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)187
8.2.1CANCER DIAGNOSTICS188
8.2.1.1High adoption of NGS in cancer diagnostics to propel growth188
TABLE 181NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)189
TABLE 182NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)189
TABLE 183EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)190
TABLE 184ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)190
TABLE 185LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)191
TABLE 186MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)191
8.2.2INFECTIOUS DISEASE DIAGNOSTICS191
8.2.2.1Applications in infectious disease surveillance and launch of new tests to drive growth191
TABLE 187NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)192
TABLE 188NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)192
TABLE 189EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)193
TABLE 190ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)193
TABLE 191LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)194
TABLE 192MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)194
8.2.3REPRODUCTIVE HEALTH DIAGNOSTICS194
8.2.3.1Extensive use of NGS in NIPT to boost growth194
TABLE 193NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)195
TABLE 194NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)196
TABLE 195EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)196
TABLE 196ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)197
TABLE 197LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)197
TABLE 198MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)197
8.2.4OTHER DIAGNOSTIC APPLICATIONS198
TABLE 199NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)198
TABLE 200NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)198
TABLE 201EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)199
TABLE 202ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)199
TABLE 203LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)200
TABLE 204MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)200
8.3DRUG DISCOVERY AND DEVELOPMENT200
TABLE 205NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY TYPE, 2020–2027 (USD MILLION)201
TABLE 206NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION)201
TABLE 207NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)202
TABLE 208EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)202
TABLE 209ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)203
TABLE 210LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION)203
TABLE 211MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION)203
8.3.1PHARMACOGENOMICS204
8.3.1.1Advent of NGS to understand genomic variants in humans to drive growth204
TABLE 212NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY REGION, 2020–2027 (USD MILLION)204
TABLE 213NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)205
TABLE 214EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)205
TABLE 215ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)206
TABLE 216LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2020–2027 (USD MILLION)206
TABLE 217MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR PHARMACOGENOMICS, BY REGION, 2020–2027 (USD MILLION)206
8.3.2OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS207
TABLE 218NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)207
TABLE 219NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)207
TABLE 220EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)208
TABLE 221ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)208
TABLE 222LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)209
TABLE 223MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR OTHER DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)209
8.4AGRICULTURAL AND ANIMAL RESEARCH209
8.4.1NGS-BASED ROUTINE SCREENING IN AGRICULTURE TO BOOST MARKET GROWTH209
TABLE 224NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY REGION, 2020–2027 (USD MILLION)210
TABLE 225NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)210
TABLE 226EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)211
TABLE 227ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)211
TABLE 228LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)212
TABLE 229MIDDLE EAST & AFRICA: NEXT-GENERATION SEQUENCING MARKET FOR AGRICULTURAL AND ANIMAL RESEARCH, BY REGION, 2020–2027 (USD MILLION)212
8.5OTHER APPLICATIONS213
TABLE 230NEXT-GENERATION SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–202
Related Report
